Study on Biomarkers of Radiation-Induced Intestinal Injury

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTongji Hospital

About this trial

1. To identify biomarkers of radiation-induced intestinal injury; 2. To develop a predictive model for radiation-induced intestinal injury.

Eligibility criteria

Qualifiers

Abdominal radiotherapy dose ≥45 Gy;

Age ≥18 years;

Karnofsky Performance Status (KPS) >60;

Expected survival >6 months.

Disqualifiers

Prior history of abdominal radiotherapy;

Active intestinal infection;

Intestinal inflammatory diseases due to other causes;

Inability to provide biological samples.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

220 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators